Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biota Pharmaceuticals Inc

+ Add to Watchlist

BOTA:US

2.4000 USD 0.0100 0.41%

As of 20:10:00 ET on 01/30/2015.

Company Profile for Biota Pharmaceuticals Inc (BOTA)

Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.

Contact Information

Biota Pharmaceuticals Inc

12270 Wilkins Avenue
Rockville, MD 20852
United States
Phone: 1-301-770-3099
Fax: 1-301-770-3097

Key Executives for Biota Pharmaceuticals Inc (BOTA)

Russell H PlumbChairmanPeter AzzarelloChief Accounting Officer
Joseph M PattiPresident/CEO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil